13.10011.73% ( -1.740 )
Closed: Nov 13, 16:00:00 (EDT)Overview
Iambic Therapeutics (IAM)
Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles a...
- Open
- 15.060
- High
- 15.060
- Low
- 12.680
- Prev. Close
- 14.840
- Volume
- 278.03K
- Turnover
- 3.76M
- Avg Price
- 13.517
- Bid/Ask Ratio
- --
- Amplitude
- 16.04%
- 52wk High
- 25.000
- Volume Ratio
- 0.00
- Turnover Ratio
- 2.33%
- 52wk Low
- 9.600
- Float Mkt Cap
- 156.49M
- Market CapUSD
- 620.95M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.99
- EPSDynamic
- -2.11
- EPSStatic
- --
- BVPS
- -4.91
- P/B
- --
- Circulating Supply
- 11.95M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 47.40M
- Min lot size
- 1
- Currency
- USD
Iambic Therapeutics Analyst Rating
View moreForecast & Rating
Nov 9, 2026Price forecast
$27.25108.02%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 3
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Weekly Review · Weekly Recap | Iambic Therapeutics +28.81%, most brokers rate it buy
Market Movers · Iambic Therapeutics tumbles 9%
Market Movers · Iambic Therapeutics tumbles 8% during regular trading
Tip Ranks · Bank of America Names 2 'Strong Buy' Stocks With 60%+ Upside
Market Movers · Iambic Therapeutics surges 8%
benzinga_article · Iambic Therapeutics Jumps 17% After-Hours as Wall Street Turns Bullish on Its AI-Powered Drug Discovery Platform
